ArticleMethods in enzymology2025
A metallophotoredox strategy for biocatalytic radical C-N
Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Metallophotoredox catalysis, an approach that combines photoredox and transition metal catalysis, has emerged as a powerful strategy in modern synthetic chemistry. This dual-catalyst system takes advantage of the broad mechanisms of photocatalysts for substrate activation and the capabilities of transition metal complexes to control reactive radical species. Its modular nature allows each catalytic component to be independently tuned for desired reactivity and selectivity. Despite its significance on synthetic methodologies, biocatalytic analogs of metallophotoredox catalysis remain largely unexplored. To bridge this gap, our group has recently discovered that several nonheme iron enzymes can be combined with synthetic photocatalysts such as eosin Y and fluorescein to enable radical generation from redox-active NHPI esters. The resulting substrate radicals can then be selectively intercepted by the enzymes to promote enantioselective transformations. Particularly, we have successfully repurposed a nonheme iron enzyme, (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis (SavHPPD), to catalyze enantioselective photoredox decarboxylative C-N
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.